Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting - TradingView

Reuters | March 18, 2026, 9:05 a.m. | Original
Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting TradingView
Iran warns of strikes on Gulf oil facilities 'in coming hours', state media reports - Reuters Belgium's imec secures rare ASML High NA EUV tool to drive next-generation chips - Reuters